Related Experiment Videos
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein
T G Thompson1, Y M Chan, A A Hack
1Howard Hughes Medical Institute and Division of Genetics, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
Mutations in genes encoding for the sarcoglycans, a subset of proteins within the dystrophin-glycoprotein complex, produce a limb-girdle muscular dystrophy phenotype; however, the precise role of this group of proteins in the skeletal muscle is not known. To understand the role of the sarcoglycan complex, we looked for sarcoglycan interacting proteins with the hope of finding novel members of the dystrophin-glycoprotein complex. Using the yeast two-hybrid method, we have identified a skeletal muscle-specific form of filamin, which we term filamin 2 (FLN2), as a gamma- and delta-sarcoglycan interacting protein. In addition, we demonstrate that FLN2 protein localization in limb-girdle muscular dystrophy and Duchenne muscular dystrophy patients and mice is altered when compared with unaffected individuals. Previous studies of filamin family members have determined that these proteins are involved in actin reorganization and signal transduction cascades associated with cell migration, adhesion, differentiation, force transduction, and survival. Specifically, filamin proteins have been found essential in maintaining membrane integrity during force application. The finding that FLN2 interacts with the sarcoglycans introduces new implications for the pathogenesis of muscular dystrophy.
Insights
Researchers identified filamin 2 (FLN2) as a protein interacting with sarcoglycans, crucial for skeletal muscle. Altered FLN2 localization in muscular dystrophy patients suggests its role in disease.
Area of Science:
- Muscle biology
- Molecular genetics
- Biochemistry
Background:
- Sarcoglycans are part of the dystrophin-glycoprotein complex, mutations cause limb-girdle muscular dystrophy.
- The exact function of sarcoglycans in skeletal muscle remains unclear.
- Understanding sarcoglycan interactions may reveal novel components of the dystrophin-glycoprotein complex.
Purpose of the Study:
- To identify proteins interacting with the sarcoglycan complex.
- To elucidate the role of sarcoglycans in skeletal muscle function and disease pathogenesis.
Main Methods:
- Yeast two-hybrid screening to identify interacting proteins.
- Western blotting and immunofluorescence to analyze protein localization in patient and mouse models.
Main Results:
- Identified skeletal muscle-specific filamin 2 (FLN2) as a gamma- and delta-sarcoglycan interacting protein.
- Demonstrated altered FLN2 protein localization in limb-girdle muscular dystrophy and Duchenne muscular dystrophy patients and mice.
- Filamin proteins are known to be involved in actin organization, signal transduction, and maintaining membrane integrity.
Conclusions:
- FLN2 interacts with sarcoglycans, suggesting a role in the dystrophin-glycoprotein complex.
- Altered FLN2 localization in muscular dystrophy indicates its involvement in disease.
- This interaction provides new insights into the pathogenesis of muscular dystrophies.